Characterization of Chlamydia pneumoniae Persistence in HEp-2 Cells Treated with Gamma Interferon
AUTOR(ES)
Pantoja, Laura G.
FONTE
American Society for Microbiology
RESUMO
Infection with Chlamydia pneumoniae has been implicated as a potential risk factor for atherosclerosis. This study demonstrated the effects of gamma interferon (IFN-γ)-mediated indoleamine 2,3-dioxygenase activity on C. pneumoniae persistence in HEp-2 cells, inclusion morphology, and ultrastructure. C. pneumoniae replication showed a dose-dependent decrease when treated with increasing concentrations of IFN-γ and a phenotypic switch resulting in a decrease in typical inclusions with an increase in smaller, less-dense atypical inclusions. Ultrastructural analysis of IFN-γ-treated C. pneumoniae revealed atypical inclusions containing large reticulatate-like aberrant bodies with no evidence of redifferentiation into elementary bodies.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=98893Documentos Relacionados
- Inhibition of Chlamydia pneumoniae growth in HEp-2 cells pretreated with gamma interferon and tumor necrosis factor alpha.
- Lymphotoxin Inhibits Chlamydia pneumoniae Growth in HEp-2 Cells
- Use of HEp-2 cells for improved isolation and passage of Chlamydia pneumoniae.
- Involvement of Nicotinic Acetylcholine Receptors in Controlling Chlamydia pneumoniae Growth in Epithelial HEp-2 Cells
- Proteomic Analysis of Differentially Expressed Chlamydia pneumoniae Genes during Persistent Infection of HEp-2 Cells
